Evolving insights regarding mechanisms for the inhibition of insulin release by norepinephrine and heterotrimeric G proteins

American Journal of Physiology - Cell Physiology

Volumn 302, Issue 12, 2012, Pages

  Sharp, Geoffrey W G ^a   Straub, Susanne G ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Adenylyl cyclases; Endocytosis; Exocytosis; Granule pools; K + channels; Pancreatic ( cell

Indexed keywords

ADENYLATE CYCLASE; ALPHA 2A ADRENERGIC RECEPTOR; CYCLIC AMP; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; NORADRENALIN; POTASSIUM CHANNEL; SNARE PROTEIN; SYNAPTOBREVIN 2; SYNAPTOSOMAL ASSOCIATED PROTEIN 23; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN 1A; SYNTAXIN 4; VOLTAGE GATED CALCIUM CHANNEL;

CALCIUM CELL LEVEL; ENDOCYTOSIS; EXOCYTOSIS; GLUCOSE METABOLISM; HORMONE INHIBITION; HUMAN; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REVIEW;

ADENYLATE CYCLASE; ANIMALS; CYCLIC AMP; DIABETES MELLITUS, TYPE 2; ENDOCYTOSIS; EXOCYTOSIS; GLUCOSE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ION CHANNEL GATING; NOREPINEPHRINE; PERTUSSIS TOXIN; POTASSIUM CHANNELS; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

EID: 84862602694     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00282.2011     Document Type: Review

References (138)

1. +Atp channels is not involved. Pflügers Arch 432: 89-96, 1996.
2. Ahrén B. The future of incretin-based therapy: novel avenues-novel targets. Diabetes Obes Metab 13, Suppl 1: 158-166, 2011.
3. 2+ influx-independent blockade of intrinsic secretion in pituitary cells by Gz subunits. J Biol Chem 280: 26896-26903, 2005.
4. Angel I, Niddam R, Langer SZ. Involvement of a-2 adrenergic receptor subtypes in hyperglycemia. J Pharmacol Exp Ther 54: 877-882, 1990.
5. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, Suda M, Koh T, Natsui K, Toyooka S, Shirakami G, Usui T, Shimatsu A, Doi K, Hosoda H, Kojima M, Kangawa K, Nakao K. Stomach is the major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86: 4753-4758, 2001.
6. 2+ channels accounts for first-phase insulin secretion in mouse β-cells. Diabetes 51, Suppl 1: S74-S82, 2002.
7. 2+ entry. Science 292: 293-297, 2001.
8. Blackmer T, Larsen EC, Takahashi M, Martin TF, Alford S, Hamm HE. G protein βγ directly regulates SNARE protein fusion machinery for secretory granule exocytosis. Nat Neurosci 8: 421-425, 2005.
9. Boesgaard TW, Grarup N, Jorgenson T, Borch-Johnsen K, Meta-Analysis of Glucose and Insulin-Related Trait Consortium (MAGIC), Hansen T, Pedersen O. Variants at DGKB/TMEM195, ADRA2A, GLIS3 and C2CD4B loci are associated with reduced glucose-stimulated (β-cell function in middle-aged Danish people. Diabetologia 53: 1647-1655, 2010.
10. Brose N, Rosenmund C. Move over protein kinase C, you've got company: alternative cellular effectors of diacylglycerol and phorbol esters. J Cell Sci 115: 4399-4411, 2002.
11. Buck J, Levin LR. Physiological sensing of carbon dioxide/bicarbon-ate/pH via cyclic nucleotide signaling. Sensors (Basel) 11: 2112-2128, 2011.
12. Cousin MA, Robinson PJ. The dephosphins: dephosphorylation by calcineurin triggers synaptic vesicle endocytosis. Trends Neurosci 24: 659-665, 2001.
13. Delint-Ramirez I, Willoughby D, Hammond GV, Ayling LJ, Cooper DM. Palmitoylation targets AKAP79 protein to lipid rafts and promotes its regulation of calcium-sensitive adenylyl cyclase type 8. J Biol Chem 286: 32962-32975, 2011.
14. Delmeire D, Flamez D, Hinke SA, Cali JJ, Pipeleers D, Schuit F. Type VIII adenylyl cyclase in rat (β-cells: coincidence signal detector/generator for glucose and GLP-1. Diabetologia 46: 1383-1393, 2003.
15. Dessauer CW. Adenylyl cyclase-A-kinase anchoring protein complexes: the next dimension in cAMP signaling. Mol Pharmacol 76: 935-941, 2009.
16. 2+ signaling in β-cells: implication in the glycemic control in rodents. Diabetes 53: 3142-3151, 2004.
17. 2+ signaling and insulin release in islet β-cells: novel signal transduction of ghrelin. Diabetes 56: 2319-2327, 2007.
18. Dezaki K, Sone H, Yada T. Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. Pharmacol Ther 118: 239-249, 2008.
19. Dornhorst A. Insulinotropic meglitinide analogues. Lancet 358: 1709-1716, 2001.
20. Dunne MJ, Cosgrove KE, Shepherd RM, Aynsley-Green A, Lindley KJ. Hyperinsulinism in infancy: from basic science to clinical disease. Physiol Rev 84: 239-275, 2004.
21. Eliasson L, Proks P, Ammälä C, Ashcroft FM, Bokvist K, Renström E, Rorsman P, Smith PA. Endocytosis of secretory granules in mouse pancreatic β-cells evoked by transient elevation of cytosolic calcium. J Physiol 493: 755-767, 1996.
22. 2+-induced exocytosis in mouse pancreatic β-cells. J Physiol 503: 399-412, 1997.
23. Furman B, Ong WK, Pyne NJ. Cyclic AMP Signaling in Pancreatic Islets. Adv Exp Med Biol 654: 281-304, 2010.
24. Gallwitz B. Glucagon-like peptide-1 analogues for Type 2 diabetes mellitus: current and emerging agents. Drugs 71: 1675-1688, 2011.
25. Gauthier BR, Wollheim CB. Synaptotagmins bind calcium to release insulin. Am J Physiol Endocrinol Metab 295: E1279-E1286, 2008.
26. 2+-exocytosis coupling in isolated mouse pancreatic β-cells. Acta Pharmacol Sin 27: 933-938, 2006.
27. Gerachshenko T, Blackmer T, Yoon EJ, Bartleson C, Hamm HE, Alford S. Gβγ acts at the C terminus of SNAP-25 to mediate presynaptic inhibition. Nat Neurosci 8: 597-605, 2005.
28. Gerich JE. Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes 51: S117-S121, 2002.
29. Gillis KD, Mossner R, Neher E. Protein kinase C enhances exocytosis from chromaffin cells by increasing the size of the readily releasable pool of secretory granules. Neuron 16: 1209-1220, 1996.
30. Gomi H, Mizutani S, Kasai K, Itohara S, Izumi T. Granuphilin molecularly docks insulin granules to the fusion machinery. J Cell Biol 171: 99-109, 2005.
31. Goubaeva F, Ghosh M, Malik S, Yang J, Hinkle PM, Griendling KK, Neubig RR, Smrcka AV. Stimulation of cellular signaling and G protein subunit dissociation by G protein βγ subunit-binding peptides. J Biol Chem 278: 19634-19641, 2003.
32. Guenifi A, Portela-Gomez GM, Grimelius L, Efendic S, Abdel-Halim SM. Adenylyl cyclase isoform expression in non-diabetic and diabetic Goto-Kakizaki (GK) rat pancreas. Evidence for distinct overexpression of type-8 adenylyl cyclase in diabetic GK rat islets. Histochem Cell Biol 113: 81-89, 2000.
33. Gulbenkian A, Schobert L, Nixon C, Tabachnick A. Metabolic effects of pertussis sensitization in mice and rats. Endocrinology 83: 885-892, 1968.
34. Hagen M, Hjelmesaeth J, Jenssen T, Morkrid L, Hartmann A. A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant 18: 2154-2159, 2003.
35. Hanna ST, Pigeau GM, Galvanovskis J, Clark A, Rorsman P, MacDonald PE. Kiss-and-run exocytosis and fusion pores of secretory vesicles in human β-cells. Pflügers Arch 457: 1343-1350, 2009.
36. Holz GG. New insights concerning the glucose-dependent insulin secre-tagogue action of glucagon-like peptide in pancreatic β-cells. Horm Metab Res 36: 787-794, 2004.
37. Holz GG. Epac: a new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic β-cell. Diabetes 53: 5-13, 2004.
38. 2+ current in the RINm5f cell line. Proc Natl Acad Sci USA 88: 8744-8748, 1991.
39. Horrigan FT, Bookman RJ. Releasable pools and the kinetics of exocytosis in adrenal chromaffin cells. Neuron 13: 1119-1129, 1994.
40. Hou JC, Min L, Pessin JE. Insulin granule biogenesis, trafficking and exocytosis. Vitam Horm 80: 473-506, 2009.
41. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CL, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LH. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273: 974-977, 1996.
42. Høy M, Efanov AM, Bertorello AM, Zaitsev SV, Olsen HL, Bokvist K, Leibiger B, Leibiger B, Leibiger IB, Zwiller J, Berggren PO, Gromada J. Inositol hexakisphosphate promotes dynamin 1-mediated endocytosis. Proc Natl Acad Sci USA 99: 6773-6777, 2002.
43. 2+ influx to inhibit insulin secretion in a hamster β-cell line: an action mediated by a guanosine triphosphate-binding protein. Endocrinology 128: 958-964, 1991.
44. Hu X, Friedman D, Hill S, Caprioli R, Nicholson W, Powers AC, Hunter L, Limbird LE. Proteomic exploration of pancreatic islets in mice null for the α2A adrenergic receptor. J Mol Endocrinol 35: 73-88, 2005.
45. Jewell JL, Oh E, Thurmond DC. Exocytosis mechanisms underlying insulin release and glucose uptake: conserved roles for Munc18c and syntaxin 4. Am J Physiol Regul Integr Comp Physiol 298: R517-R531, 2010.
46. 2+-induced insulin secretion from electrically permeabilised islets of Langerhans. FEBS Lett 219: 139-144, 1987.
47. Josefsen K, Lee YC, Thams P, Efendic S, Nielsen JH. AKAP 18 alpha and gamma have opposing effects on insulin release in INS-1E cells. FEBS Lett 584: 81-85, 2010.
48. 2+ release and exocytosis in pancreatic β-cells. J Biol Chem 278: 8279-8285, 2003.
49. Kasai K, Fujita T, Gomi H, Izumi T. Docking is not a prerequisite but a temporal restraint for fusion of secretory granules. Traffic 9: 1191-1203, 2008.
50. Kasai K, Ohara-Imaizumi M, Takahashi N, Mizutani S, Zhao S, Kikuta H, Kasai H, Nagamatsu S, Gomi H, Izumi T. Rab27a mediates the tight docking of insulin granules onto the plasma membrane during glucose stimulation. J Clin Invest 115: 388-399, 2005.
51. Kashima Y, Miki T, Shibasaki T, Ozaki N, Miyazaki M, Yano H, Seino S. Critical role of cAMP-GEFII-Rim2 complex in incretin-poten-tiated insulin secretion. J Biol Chem 276: 46046-46053, 2001.
52. Katada T, Tamura M, Ui M. The A protomer of islet-activating protein, pertussis toxin, as an active peptide catalyzing ADP-ribosylation of a membrane protein. Arch Biochem Biophys 224: 290-298, 1983.
53. Katada T, Ui M. Effect of in vivo pretreatment of rats with a new protein purified from Bordetella pertussis on in vitro secretion of insulin: role of calcium. Endocrinology 104: 1822-1827, 1979.
54. Katada T, Ui M. Slow interaction of islet-activating protein with pancreatic islets during primary culture to cause reversal of α-adrenergic inhibition of insulin secretion. J Biol Chem 255: 9580-9588, 1980.
55. Katada T, Ui M. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation. Proc Nat1 Acad Sci USA 79: 3129-3133, 1982.
56. Katada T, Ui M. ADP ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity. J Biol Chem 257: 7210-7216, 1982.
57. Kimple ME, Joseph JW, Bailey CL, Fueger PT, Hendry IA, New-gard CB, Casey PJ. Gαz negatively regulates insulin secretion and glucose clearance. J Biol Chem 283: 4560-4567, 2008.
58. Kimple ME, Nixon AB, Kelly P, Bailey CL, Young KH, Fields TA, Casey PJ. A role for Gz in pancreatic islet β-cell biology. J Biol Chem 280: 31708-31713, 2005.
59. Kimura T, Kaneko Y, Yamada S, Ishihara H, Senda T, Iwamatsu A, Niki I. The GDP-dependent Rab27a effector coronin 3 controls endocy-tosis of secretory membrane in insulin-secreting cell lines. J Cell Sci 121: 3092-3098, 2008.
60. Knowler WC, Narayan KM, Hanson RL, Nelson RG, Bennett PH, Tuomilehto J, Scherstén B, Pettitt DJ. Preventing non-insulin-dependent diabetes. Diabetes 44: 483-488, 1995.
61. Komatsu M, McDermott AM, Gillison SL, Sharp GWG. Time course of action of pertussis toxin to block the inhibition of stimulated insulin release by norepinephrine. Endocrinology 136: 1857-1863, 1995.
62. Kowluru A. Small G proteins in islet β-cell function. Endocr Rev 31: 52-78, 2010.
63. Kuliawat R, Kalinina E, Bock J, Fricker L, McGraw TE, Kim SR, Zhong J, Scheller R, Arvan P. Syntaxin-6 SNARE involvement in secretory and endocytic pathways of cultured pancreatic β-cells. Mol Biol Cell 15: 1690-1701, 2004.
64. Kwan EP, Xie L, Sheu L, Nolan CJ, Prentki M, Betz A, Brose N, Gaisano HY. Munc13-1 deficiency reduces insulin secretion and causes abnormal glucose tolerance. Diabetes 55: 1421-1429, 2006.
65. Lang J. Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. Eur J Biochem 259: 3-17, 1999.
66. Leech CA, Castonguay MA, Habener JF. Expression of adenylyl cyclase subtypes in pancreatic β-cells. Biochem Biophys Res Commun 2: 703-706, 1999.
67. Ljubicic S, Bezzi P, Vitale N, Regazzi R. The GTPase RalA regulates different steps of the secretory process in pancreatic β-cells. PLos One 4: e7770, 2009.
68. Lopez JA, Kwan EP, Xie L, He Y, James DE, Gaisano HY. The RalA GTPase is a central regulator of insulin exocytosis from pancreatic islet β-cells. J Biol Chem 283: 17939-17945, 2008.
69. Lu J, He Z, Fan J, Xu P, Chen L. Overlapping functions of different dynamin isoforms in clathrin-dependent and -independent endocytosis in pancreatic β-cells. Biochem Biophys Res Commun 371: 315-319, 2008.
70. Luttrell LM, van Biesen T, Hawes BE, Koch WJ, Krueger KM, Touhara K, Lefkowitz RJ. G-protein-coupled receptors and their regulation: activation of the MAP kinase signaling pathway by G-protein-coupled receptors. Adv Second Messenger Phosphoprotein Res 31: 263-277, 1997.
71. Ma L, Bindokas VP, Kuznetsov A, Rhodes C, Hays L, Edwardson JM, Ueda K, Steiner DF, Philipson LH. Direct imaging shows that insulin granule exocytosis occurs by complete vesicle fusion. Proc Natl Acad Sci USA 101: 9266-9271, 2004.
72. MacDonald PE, Eliasson L, Rorsman P. Calcium increases endocy-totic vesicle size and accelerates membrane fission in insulin-secreting INS-1 cells. J Cell Sci 118: 5911-5920, 2005.
73. MacDonald PE, Rorsman P. The ins and outs of secretion from pancreatic (β-cells: control of single-vesicle exo- and endocytosis. Physiology 22: 113-121, 2007.
74. McDermott AM, Sharp GWG. Inhibition of insulin secretion: a failsafe system. Cell Signal 5: 229-234, 1993.
75. McDermott AM, Sharp GWG. Gi2 and Gi3 proteins mediate the inhibition of adenylyl cyclase by galanin in the RINm5F cell. Diabetes 44: 453-459, 1995.
76. Mandarino L, Itoh M, Blanchard W, Patton G, Gerich JE. Stimulation of insulin release in the absence of extracellular calcium by isobu-tylmethylxanthine and its inhibition by somatostatin. J Endocrinol 106: 430-433, 1980.
77. Merrins MJ, Stuenkel EL. Kinetics of Rab27a-dependent actions on vesicle docking and priming in pancreatic β-cells. J Physiol 586: 5367-5381, 2008.
78. Michel MC, Plogmann C, Philipp T, Brodde OE. Functional correlates of α2A-adrenoceptor gene polymorphism in the HANE study. Nephrol Dial Transplant 14: 2657-2663, 1999.
79. Min L, Leung YM, Tomas A, Watson RT, Gaisano HY, Halban PA, Pessin JE, Hou JC. Dynamin is functionally coupled to insulin granule exocytosis. J Biol Chem 282: 33530-33536, 2007.
80. Mourad NI, Nenquin M, Henquin JC. Metabolic amplifying pathway increases both phases of insulin secretion independently of β-cell actin microfilaments. Am J Physiol Cell Physiol 299: C389-C398, 2010.
81. Nagamatsu S, Nakamichi Y, Watanabe T, Matsushima S, Yamagu-chi S, Ni J, Itagaki E, Ishida H. Localization of cellubrevin-related peptide, endobrevin, in the early endosome in pancreatic β cells and its physiological function in exo-endocytosis of secretory granules. J Cell Sci 114: 219-227, 2001.
82. Nesher R, Cerasi E. Modeling phasic insulin release: immediate and time-dependent effects of glucose. Diabetes 51, Suppl 1: S53-S59, 2002.
83. Niddam R, Angel I, Bidet S, Langer SZ. Pharmacological characterization of alpha-2 adrenergic receptor subtype involved in the release of insulin from isolated rat pancreatic islets. J Pharmacol Exp Ther 254: 883-887, 1990.
84. 2+ concentration determines type of fusing insulin granules in pancreatic beta cells. Biochem Biophys Res Commun 385: 291-295, 2009.
85. Ohara-Imaizumi M, Fujiwara T, Nakamichi Y, Okamura T, Akimoto Y, Kawai J, Matsushima S, Kawakami H, Watanabe T, Akagawa K, Nagamatsu S. Imaging analysis reveals mechanistic differences between first- and second-phase insulin exocytosis. J Cell Biol 177: 695-705, 2007.
86. Ohara-Imaizumi M, Nakamichi Y, Tanaka T, Katsuta H, Ishida H, Nagamatsu S. Monitoring of exocytosis and endocytosis of insulin secretory granules in the pancreatic β-cell line MIN6 using pH-sensitive green fluorescent protein (pHluorin) and confocal laser microscopy. Biochem J 363: 73-80, 2002.
87. Orci L, Malaisse-Lagae F, Ravazzola M, Amherdt M, Renold AE. Exocytosis-endocytosis coupling in the pancreatic β-cell. Science 181: 561-562, 1973.
88. Ostrom RS, Bogard AS, Gros R, Feldman RD. Choreographing the adenylyl cyclase signalosome: sorting out the partners and the steps. Naunyn Schmiedebergs Arch Pharmacol 385: 5-12, 2012.
89. Peterhoff M, Sieg A, Brede M, Chao CM, Hein L, Ullrich S. Inhibition of insulin secretion via distinct signaling pathways in α2-adrenoceptor knockout mice. Eur J Endocrinol 149: 343-350, 2003.
90. Petit P, Loubatières-Mariani MM. Potassium channels of the insulin-secreting β cell. Fundam Clin Pharmacol 6: 123-134, 1992.
91. Proks P, Ashcroft FM. Effects of divalent cations on exocytosis and endocytosis from single mouse pancreatic β-cells. J Physiol 487: 465-477, 1995.
92. Redmon JB, Olson LK, Armstrong MB, Greene MJ, Robertson RP. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invest 98: 2786-2793, 1996.
93. Régnauld KL, Leteurtre E, Gutkind SJ, Gespach CP, Emami S. Activation of adenylyl cyclases, regulation of insulin status, and cell survival by Gαolf in pancreatic β-cells. Am J Physiol Regul Integr Comp Physiol 282: R870-R880, 2002.
94. Renström E, Eliasson L, Rorsman P. Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic β-cells. J Physiol 502: 105-118, 1997.
95. +atp channel in insulin secreting mammalian HIT and RIN cell lines. J Physiol 485: 73-86, 1995.
96. Rizzoli SO, Jahn R. Kiss-and-run, collapse and "readily retrievable" vesicles. Traffic 8: 1137-1144, 2007.
97. Rodriguez-Pena MS, Collins R, Woodard C, Spiegel AM. Decreased insulin content and secretion in RIN-1046-38 cells over-expressing α2-adrenergic receptors. Endocrine 7: 255-260, 1997.
98. + channel in mouse pancreatic β-cells. Nature 349: 77-79, 1991.
99. Rosengren AH, Jokubka R, Tojjar D, Granhall C, Hansson O, Li DQ, Nagaraj V, Reinbothe TM, Tuncel J, Eliasson L, Groop L, Rorsman P, Salehi A, Lyssenko V, Luthman H, Renström E. Over-expression of α2A-adrenergic receptors contributes to type 2 diabetes. Science 327: 217-220, 2010.
100. Samols E, Marrii G, Marks V. Promotion of insulin secretion by glucagon. Lancet 2: 415-416, 1965.
101. 2+]i in oscillating and non-oscillating HIT-T15 cells. Cell Calcium 27: 163-173, 2000.
102. Seaquist ER, Walseth TF, Redmon JB, Robertson RP. G-protein regulation of insulin secretion. J Lab Clin Med 123: 338-345, 1994.
103. Seino S, Shibasaki T. PKA-dependent and PKA-independent pathways for cAMP- regulated exocytosis. Physiol Rev 85: 1303-1342, 2005.
104. Sharp GWG. Mechanisms of inhibition of insulin release. Am J Physiol Cell Physiol 271: C1781-C1799, 1996.
105. Sharp GWG, Le Marchand-Brustel Y, Yada T, Russo LL, Bliss CR, Cormont M, Monge L, Van Obberghen E. Galanin can inhibit insulin release by a mechanism other than membrane hyperpolarization or inhibition of adenylate cyclase. J Biol Chem 264: 7302-7309, 1989.
106. Shibasaki T, Takahashi H, Miki T, Sunaga Y, Matsumara K, Ya-manaka M, Zhang C, Tamamoto A, Satoh T, Miyazaki J, Seino S.Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP. Proc Natl Acad Sci USA 104: 19333-19338, 2007.
107. Sieg A, Su J, Munoz A, Buchenau M, Nakazaki M, Aguilar-Bryan L, Bryan J, Ullrich S. Epinephrine-induced hyperpolarization of islet cells without KATP channels. Am J Physiol Endocrinol Metab 286: E463-E471, 2004.
108. Smillie KJ, Cousin MA. Dynamin 1 phosphorylation and the control of synaptic vesicle endocytosis. Biochem Soc Symp 72: 87-97, 2005.
109. 2+ acts by two separate pathways to modulate the supply of release-competent vesicles in chromaffin cells. Neuron 20: 1243- 1253, 1998.
110. Smith C, Neher E. Multiple forms of endocytosis in bovine adrenal chromaffin cells. J Cell Biol 139: 885-894, 1997.
111. Sovantus E, Fagerholm V, Rahkonen O, Scheinin M. Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in α2A-adrenergic receptor knockout mice. Eur J Pharmacol 578: 359-364, 2008.
112. Stevens CF, Sullivan JM. Regulation of the readily releasable vesicle pool by protein kinase C. Neuron 21: 885-893, 1998.
113. Straub SG, Shanmugam G, Sharp GWG. Stimulation of insulin release by glucose is associated with an increase in the number of docked granules in the β-cells of rat pancreatic islets. Diabetes 53: 3179-3183, 2004.
114. Straub SG, Sharp GWG. Glucose-stimulated signaling pathways in biphasic insulin secretion. Diabetes Metab Res Rev 18: 451-463, 2002.
115. Straub SG, Sharp GWG. Hypothesis: one rate-limiting step controls the magnitude of both phases of glucose-stimulated insulin secretion. Am J Physiol Cell Physiol 287: C565-C571, 2004.
116. Südhof TC, Rothman JE. Membrane fusion: grappling with SNARE and SM proteins. Science 323: 474-477, 2009.
117. Sugawara K, Shibasaki T, Mizoguchi A, Saito T, Seino S. Rab11 and its effector Rip11 participate in regulation of insulin granule exocytosis. Genes Cells 14: 445-456, 2009.
118. Szentivanyi A, Fishel CW, Talmadge DW. Adrenal mediation of histamine and serotonin hyperglycemia in normal mice and the absence of adrenal-induced hyperglycemia in pertussis sensitized mice. J Infect Dis 113: 86-91, 1963.
119. + channels. J Biol Chem 282: 1747-1756, 2006.
120. + channels. Br J Pharmacol 159: 669-677, 2010.
121. Toyota T, Kakizaki M, Kimura K, Yajima M, Okamoto T, Ui M. Islet activating protein (IAP) derived from the culture supernatant fluid of Bordetella pertussis: effect on spontaneous diabetic rats. Diabetologia 14: 319-323, 1978.
122. Tsuboi T, McMahon HT, Rutter GA. Mechanisms of dense core vesicle recapture following "kiss and run" ("cavicapture") exocytosis in insulin-secreting cells. J Biol Chem 279: 47115-47124, 2004.
123. Turner JH, Garnovskaya MN, Raymond JR. Serotonin 5-HT1A receptor stimulates c-Jun N-terminal kinase and induces apoptosis in Chinese hamster ovary fibroblasts. Biochim Biophys Acta 1773: 391- 399, 2007.
124. 2+ and insulin release. Mol Pharmacol 28: 100-106, 1985.
125. Voets T, Neher E, Moser T. Mechanisms underlying phasic and sustained secretion in chromaffin cells from mouse adrenal slices. Neuron 23: 607-615, 1999.
126. 2+. J Gen Physiol 124: 653-662, 2004.
127. Wang Y, Park Bajpayee NS S, Nagaoka Y, Boulay G, Birnbaumer L. Augmented glucose-induced insulin release in mice lacking Go2, but not Go1 or Gi proteins. Proc Natl Acad Sci USA 108: 1693-1698, 2011.
128. Wang Z, Thurmond DC. Mechanisms of biphasic insulin-granule exocytosis-roles of the cytoskeleton, small GTPases and SNARE proteins. J Cell Sci 122: 893-903, 2009.
129. 2+ fluxes and insulin release in rat pancreatic islets maintained in tissue culture. J Clin Invest 60: 1165-1173, 1977.
130. Yawo H. Two components of transmitter release from the chick presynaptic terminal and their regulation by protein kinase C. J Physiol 516: 461-470, 1999.
131. Yaekura K, Julyan R, Wicksteed BL, Hays LB, Alarcon C, Sommers S, Poitout V, Baskin DG, Wang Y, Philipson LH, Rhodes CJ. Insulin secretory deficiency and glucose intolerance in Rab3a null mice. J Biol Chem 278: 9715-9721, 2003.
132. Yi Z, Yokota H, Torii S, Aoki T, Hosaka M, Zhao S, Takata K, Takeuchi T, Izumi T. The Rab27a/granuphilin complex regulates the exocytosis of insulin-containing dense-core granules. Mol Cell Biol 22: 1858-1867, 2002.
133. Yajima M, Hosoda K, Kanbayashi Y, Nakamura T, Nogimori K, Nakase Y, Ui M. Islet-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory response of rats: purification and characterization. J Biochem 83: 295-303, 1978.
134. 2+-sensitive pool of granules is regulated by glucose and protein kinases in insulin-secreting INS-1 cells. J Gen Physiol 124: 641-651, 2004.
135. Zhao Y, Fang Q, Straub SG, Lindau M, Sharp GWG. Noradrenaline inhibits exocytosis via the G protein βγ subunit and refilling of the readily releasable granule pool via the αi1/2 subunit. J Physiol 588: 3485-3498, 2010.
136. Zhao Y, Fang Q, Straub SG, Lindau M, Sharp GWG. Hormonal inhibition of endocytosis: novel roles for noradrenaline and G-protein Gz. J Physiol 588: 3499-3509, 2010.
137. Zhao Y, Fang Q, Straub SG, Sharp GWG. Both Gi and Go heterotri-meric proteins are required to exert the full effect of norepinephrine on the β-cell Katp channel. J Biol Chem 283: 5306-5316, 2008.
138. Zhao A, Ohara-Imaizui M, Brissova M, Benninger RKP, Xu Y, Hao Y, Abramowitz J, Boulay G, Powers AC, Piston D, Jiang M, Nas-gamatsu S, Birnbaumer L, Gu G. Goto represses insulin secretion by reducing vesicular docking in pancreatic β-cells. Diabetes 59: 2522-2529, 2010.